本页面由Tiger Trade Technology Pte. Ltd.提供服务

Psyence Biomedical Ltd

4.29
-0.0400-0.92%
成交量:3,712
成交额:1.59万
市值:1,636.33万
市盈率:-0.34
高:4.29
开:4.29
低:4.29
收:4.33
52周最高:34.63
52周最低:1.92
股本:381.43万
流通股本:109.46万
量比:2.76
换手率:0.34%
股息:- -
股息率:- -
每股收益(TTM):-12.5596
每股收益(LYR):-12.5596
净资产收益率:-58.62%
总资产收益率:-31.33%
市净率:0.97
市盈率(LYR):-0.34

数据加载中...

2026/06/23

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/06/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025/10/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/10/06

SEC问询函

Form CORRESP - Correspondence
2025/10/06

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/07/25

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/07/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/13

SEC问询函

Form CORRESP - Correspondence
2025/01/28

SEC问询函

Form CORRESP - Correspondence
2025/01/24

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/12/30

SEC问询函

Form CORRESP - Correspondence
2024/12/20

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/12/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/12/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

SEC问询函

Form CORRESP - Correspondence